4.74% 0.19

Arbutus Biopharma Corp (ABUS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Arbutus Biopharma Corp Azioni (ABUS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	508.79% 10.74	1.764	1.574	1.339	1.726
Operating Expenses	66.31% 9.251	27.46	15.51	22.78	23.31
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	66.31% 9.251	27.46	15.51	22.78	23.31
Operating Income/Loss	105.79% 1.488	-25.70	-13.93	-21.44	-21.58
Nonoperating Income/Loss	11.76% 1.035	1.173	1.401	1.723	1.787
Income/Loss From Continuing Operations Before Tax	143.79% 10.74	-24.53	1.574	1.339	-19.80
Income/Loss From Continuing Operations After Tax	110.29% 2.523	-24.53	-12.53	-19.72	-19.80
Net Income/Loss	110.29% 2.523	-24.53	-12.53	-19.72	-19.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.44% 191.55	190.71	1.3641	189.00	188.04
Diluted Average Shares	0.89% 192.40	190.71	-367.06	189.00	188.04
Basic Earnings Per Share	107.69% 0.01	-0.13	-0.07	-0.10	-0.11
Diluted Earnings Per Share	107.69% 0.01	-0.13	-0.07	-0.10	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%